Morpholino

MO2-ptmab

ID
ZDB-MRPHLNO-131125-5
Name
MO2-ptmab
Previous Names
None
Target
Sequence
5' - TGTGTATCAATAGAATTGGAGCGCA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO, targets the 5'UTR.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-ptmab
No data available
Phenotype
Phenotype resulting from MO2-ptmab
Phenotype of all Fish created by or utilizing MO2-ptmab
Phenotype Fish Conditions Figures
caudal fin curved, abnormal WT + MO1-ptmab + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
spinal cord bent, abnormal WT + MO1-ptmab + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
pericardium edematous, abnormal WT + MO1-ptmab + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
trunk curved, abnormal WT + MO1-ptmab + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
head decreased size, abnormal WT + MO1-ptmab + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
whole organism decreased size, abnormal WT + MO1-ptmab + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
caudal fin bent, abnormal WT + MO1-ptmab + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
pericardium edematous, abnormal WT + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
head decreased size, abnormal WT + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
caudal fin curved, abnormal WT + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
trunk curved, abnormal WT + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
caudal fin bent, abnormal WT + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
spinal cord bent, abnormal WT + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
whole organism decreased size, abnormal WT + MO2-ptmab standard conditions Fig. 2 from Emmanouilidou et al., 2013
Citations